Related references
Note: Only part of the references are listed.Patterns of Emergency Medical Services Use and Its Association With Timely Stroke Treatment Findings From Get With the Guidelines-Stroke
Olaniyi James Ekundayo et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Edward C. Jauch et al.
STROKE (2013)
Safety of Thrombolysis in Patients Over the Age of 80
Joshua Zebadiah Willey et al.
NEUROLOGIST (2012)
Factors Associated With Prehospital Delays in the Presentation of Acute Stroke in Urban China
Haiqiang Jin et al.
STROKE (2012)
Times From Symptom Onset to Hospital Arrival in the Get With The Guidelines-Stroke Program 2002 to 2009 Temporal Trends and Implications
David Tong et al.
STROKE (2012)
Predictors of Rapid Brain Imaging in Acute Stroke Analysis of the Get With The Guidelines-Stroke Program
Adam G. Kelly et al.
STROKE (2012)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States A Doubling of Treatment Rates Over the Course of 5 Years
Opeolu Adeoye et al.
STROKE (2011)
Improving Door-to-Needle Times in Acute Ischemic Stroke The Design and Rationale for the American Heart Association/American Stroke Association's Target: Stroke Initiative
Gregg C. Fonarow et al.
STROKE (2011)
Hospital-Level Variation in Mortality and Rehospitalization for Medicare Beneficiaries With Acute Ischemic Stroke
Gregg C. Fonarow et al.
STROKE (2011)
Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke
Gregg C. Fonarow et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Trends in Thrombolytic Use for Ischemic Stroke in the United States
Margaret C. Fang et al.
JOURNAL OF HOSPITAL MEDICINE (2010)
Translating Evidence Into Practice: A Decade of Efforts by the American Heart Association/American Stroke Association to Reduce Death and Disability Due to Stroke A Presidential Advisory From the American Heart Association/American Stroke Association
Lee Schwamm et al.
STROKE (2010)
Acute Stroke Therapy With Tissue Plasminogen Activator (tPA) Since It Was Approved by the US Food and Drug Administration (FDA)
Justin A. Zivin
ANNALS OF NEUROLOGY (2009)
Get With the Guidelines-Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack
Lee H. Schwamm et al.
CIRCULATION (2009)
Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke
EE Smith et al.
STROKE (2005)
TPA use for stroke in the Registry of the Canadian Stroke Network
JO Nadeau et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2005)
Thrombolysis for ischemic stroke in the United States: Data from National Hospital Discharge Survey 1999-2001
AI Qureshi et al.
NEUROSURGERY (2005)
Recommendations for the establishment of stroke systems of care - Recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems - Task force members
LH Schwamm et al.
CIRCULATION (2005)
Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
IL Katzan et al.
ARCHIVES OF NEUROLOGY (2004)
Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke - A population-based study
D Kleindorfer et al.
STROKE (2004)
Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility
JN Fink et al.
NEUROLOGY (2001)
Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience
IL Katzan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
